The question hanging over Barclays this morning is not whether the bank broke a rule. It is whether anyone, including the bank itself, can accurately value what it owns.

The Bank of England’s Prudential Regulation Authority is examining allegations that Barclays misclassified derivatives linked to illiquid private credit loans, potentially understating the risks and capital required to support its exposure. The regulator received a complaint earlier this year concerning the bank’s use of total return swaps to finance loans held by private credit funds. Barclays shares fell 2.3% in early London trade.

The Mechanics Matter

The complaint centres on Barclays’ allocation of total return swaps referencing illiquid private credit loans to its trading book. Total return swaps are derivatives that allow one party to receive the economic performance of an asset in exchange for a fee-like stream of payments, often used to provide synthetic exposure or financing. Barclays traders argued that back-to-back swaps hedging their exposure made the positions tradable, despite the underlying loans being illiquid.

That argument matters enormously for capital. Banking-book assets generally attract higher capital requirements, while trading-book treatment can reduce the capital banks must hold against certain positions. Incorrect classification could therefore lower funding costs while increasing the risk that losses are inadequately covered. In a letter to finance directors last year, the PRA expressly warned banks against seeking to game the capital rules by repackaging illiquid assets as tradeable ones.

Why Wall Street Is Paying Attention

This is not an isolated compliance story. It arrives during a week when private credit’s marks are under simultaneous attack from multiple directions. Borrowers in the US private debt market are using delayed interest payments and maturity extensions to avoid default, potentially masking the overall extent of credit stress, according to Moody’s Ratings. The default rate among 607 private credit borrowers assessed by Moody’s stood at 4% in the 12 months to June 2026, but that figure rose to 5.8% when payment-in-kind amendments and maturity extensions among distressed issuers were taken into account.

The private credit warning from the IMF is quieter, but in some ways more structurally significant. The fund has warned that private credit now rivals other major credit markets in size, and that leverage and contingent liquidity risks could amplify stress. The through-line is consistent: reported numbers understate actual stress.

The Barclays probe makes that problem bank-specific and regulatory, not merely analytical. The scrutiny comes amid broader regulatory concerns about links between banks and the private credit market, as lenders increasingly provide financing to private credit funds. Seven major European banks, including Deutsche Bank, BNP Paribas, Barclays, HSBC, Société Générale, Santander, and Crédit Agricole, have a combined direct lending exposure to private credit funds of roughly €108 billion, representing about 2% of their total customer loans, according to S&P Global Ratings estimates.

The Question Investors Are Really Asking

Bear-case investors have argued for months that European bank capital ratios look solid only because the illiquid assets financing private credit funds are not being marked at what a stressed sale would yield. The Barclays complaint, regardless of its outcome, crystallises that concern into something with a regulator’s name on it.

Bank of America Global Research has described banks’ private credit exposure as remaining opaque. That word is doing significant work right now. The revelation arrives just as Barclays approaches a key reporting date: the bank is due to publish its Q3 2026 results on October 22, 2026. Portfolio managers who were modelling a clean earnings week now have a capital adequacy question they cannot easily price.

The bull case is that Barclays’ private credit exposure sits within a much larger, diversified book, that no regulatory finding has been made, and that the bank has consistently described its private credit activity as concentrated in senior lending to large established managers. Bears counter that the very opacity Moody’s and the IMF flagged this week makes that reassurance difficult to verify independently.

Stocks to Watch

• Barclays (BARC): The subject of the probe and reporting Q3 results imminently. Expect private credit capital treatment to dominate analyst questions Thursday.
• Deutsche Bank: Its private credit portfolio stood at €25.9 billion, the highest disclosed figure among major European banks in S&P Global Ratings’ summary of bank exposures. Any re-rating of how European regulators treat these books hits Deutsche hardest on a relative basis.
• HSBC: HSBC booked a one-off charge tied to exposure linked to the collapse of Market Financial Solutions earlier this year, as reported by Reuters. A second wave of regulatory questions about book classification adds incremental risk.
• Blue Owl Capital: Among the largest providers of private credit to the funds that banks are financing. If bank counterparties face higher capital charges, the economics of those financing arrangements tighten from both ends.

The PRA has not announced a finding. Barclays may well clear the inquiry cleanly. But the market is no longer willing to take the underlying valuations on faith, and that scepticism, once established, does not wait for regulators to finish their work.